LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Timepoint Timepoint Unit Mean Total Cell Count Before Treatment Mean Total Cell Count After Treatment Mean Total Control Cell Count Mean Relative Cell Count Mean Relative Growth Rate After Treatment
SK-BR-3 Withaferin A
3.33
uM
LJP5
 72
hr
 1476 829 3694 0.2245 -0.2920
MCF7 AZD 5438
10.0
uM
LJP6
 72
hr
 1235 381 4156 0.0917 -0.2925
SK-BR-3 SNS-032
10.0
uM
LJP6
 72
hr
 1476 823 3694 0.2230 -0.2945
SK-BR-3 HG-6-64-01
10.0
uM
LJP6
 72
hr
 1476 809 3694 0.2192 -0.3008
SK-BR-3 AZD 5438
10.0
uM
LJP6
 72
hr
 1476 807 3694 0.2186 -0.3017
SK-BR-3 AT-7519
10.0
uM
LJP6
 72
hr
 1476 788 3694 0.2133 -0.3106
SK-BR-3 Omipalisib
10.0
uM
LJP6
 72
hr
 1476 765 3694 0.2073 -0.3207
SK-BR-3 GSK1059615
10.0
uM
LJP5
 72
hr
 1476 757 3694 0.2051 -0.3243
SK-BR-3 CGP60474
10.0
uM
LJP6
 72
hr
 1476 732 3694 0.1983 -0.3356
SK-BR-3 Geldanamycin
10.0
uM
LJP6
 72
hr
 1476 688 3694 0.1864 -0.3554
SK-BR-3 LDN-193189
10.0
uM
LJP5
 72
hr
 1476 662 3694 0.1794 -0.3671
SK-BR-3 QL-XII-47
10.0
uM
LJP6
 72
hr
 1476 659 3694 0.1786 -0.3685
SK-BR-3 Mitoxantrone
10.0
uM
LJP5
 72
hr
 1476 630 3694 0.1707 -0.3816
SK-BR-3 Geldanamycin
10.0
uM
LJP5
 72
hr
 1476 597 3694 0.1616 -0.3968
SK-BR-3 Mitoxantrone
10.0
uM
LJP6
 72
hr
 1476 544 3694 0.1474 -0.4204